Source:http://linkedlifedata.com/resource/pubmed/id/10325657
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-5-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1462-0324
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
198-201
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10325657-Bone Density,
pubmed-meshheading:10325657-Clinical Trials as Topic,
pubmed-meshheading:10325657-Diphosphonates,
pubmed-meshheading:10325657-Female,
pubmed-meshheading:10325657-Humans,
pubmed-meshheading:10325657-Osteoporosis, Postmenopausal,
pubmed-meshheading:10325657-Risk Factors,
pubmed-meshheading:10325657-Steroids
|
pubmed:year |
1999
|
pubmed:articleTitle |
Management of steroid-induced osteoporosis: what is the current state of play?
|
pubmed:publicationType |
Editorial
|